Technical Articles
Targeted protein degradation
CRBN-DDB1 and Molecular Glues: From the Thalidomide Controversy to the New Paradigm of Targeted Degradation
A once-withdrawn old drug revealed, sixty years later, an entirely new paradigm of targeted protein degradation. This article follows the timeline of how CRBN-DDB1 moved from the thalidomide mystery to center stage of molecular glue therapeutics.
View details
- Drug Research
- CRBN-DDB1
- Molecular glue
- Thalidomide
- Lenalidomide
- Targeted protein degradation
- UA085062
The CRBN E3 ligase in targeted protein degradation technology and its application advantages
Targeted Protein Degradation (TPD) technology is a hot field in recent drug development.
View details
- Drug Research
- VAV1/CRBN PROTAC Kit
- Targeted protein degradation
- E3 ligase
- 1














